Zacks: Brokerages Expect Express Scripts Holding Company (ESRX) Will Announce Quarterly Sales of $25.38 Billion
Equities analysts forecast that Express Scripts Holding Company (NASDAQ:ESRX) will announce $25.38 billion in sales for the current quarter, according to Zacks Investment Research. Nine analysts have provided estimates for Express Scripts Holding’s earnings. The lowest sales estimate is $24.77 billion and the highest is $26.19 billion. Express Scripts Holding reported sales of $25.22 billion in the same quarter last year, which suggests a positive year over year growth rate of 0.6%. The firm is scheduled to announce its next quarterly earnings results after the market closes on Tuesday, July 25th.
According to Zacks, analysts expect that Express Scripts Holding will report full year sales of $25.38 billion for the current fiscal year, with estimates ranging from $99.93 billion to $103.96 billion. For the next fiscal year, analysts forecast that the firm will report sales of $104.22 billion per share, with estimates ranging from $102.37 billion to $106.85 billion. Zacks Investment Research’s sales averages are an average based on a survey of analysts that cover Express Scripts Holding.
Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings results on Monday, April 24th. The company reported $1.33 EPS for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.01. Express Scripts Holding had a return on equity of 25.64% and a net margin of 3.42%. The company had revenue of $24.65 billion during the quarter, compared to analysts’ expectations of $24.95 billion. During the same period in the prior year, the company earned $1.22 EPS. Express Scripts Holding’s revenue was down .6% compared to the same quarter last year.
Several brokerages recently issued reports on ESRX. Argus reiterated a “hold” rating on shares of Express Scripts Holding in a research report on Wednesday, March 29th. Edward Jones lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Wednesday, April 26th. Jefferies Group LLC set a $88.00 target price on shares of Express Scripts Holding and gave the stock a “buy” rating in a research report on Thursday, April 20th. SunTrust Banks, Inc. reiterated a “buy” rating on shares of Express Scripts Holding in a research report on Tuesday, April 25th. Finally, UBS AG set a $71.00 target price on shares of Express Scripts Holding and gave the stock a “hold” rating in a research report on Tuesday, April 25th. Four investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $71.89.
Express Scripts Holding (NASDAQ ESRX) opened at 62.05 on Thursday. The stock has a 50 day moving average price of $62.66 and a 200-day moving average price of $65.49. The company has a market capitalization of $36.83 billion, a PE ratio of 11.25 and a beta of 0.90. Express Scripts Holding has a 52 week low of $57.80 and a 52 week high of $79.50.
In related news, VP Phyllis S. Anderson sold 1,100 shares of the business’s stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $60.08, for a total transaction of $66,088.00. Following the transaction, the vice president now owns 11,108 shares in the company, valued at $667,368.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.68% of the stock is owned by insiders.
Several institutional investors have recently made changes to their positions in ESRX. Senzar Asset Management LLC bought a new position in shares of Express Scripts Holding during the fourth quarter valued at about $30,749,000. Jarislowsky Fraser Ltd bought a new position in shares of Express Scripts Holding during the fourth quarter valued at about $540,000. Numeric Investors LLC boosted its position in shares of Express Scripts Holding by 9.3% in the fourth quarter. Numeric Investors LLC now owns 2,208,889 shares of the company’s stock valued at $151,949,000 after buying an additional 187,889 shares in the last quarter. Westwood Holdings Group Inc. boosted its position in shares of Express Scripts Holding by 34.6% in the fourth quarter. Westwood Holdings Group Inc. now owns 60,300 shares of the company’s stock valued at $4,148,000 after buying an additional 15,500 shares in the last quarter. Finally, Thrivent Financial for Lutherans boosted its position in shares of Express Scripts Holding by 16.5% in the fourth quarter. Thrivent Financial for Lutherans now owns 943,111 shares of the company’s stock valued at $64,877,000 after buying an additional 133,760 shares in the last quarter. Institutional investors own 88.47% of the company’s stock.
Express Scripts Holding Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.